Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

CyDex Pharmaceuticals licenses compound that could expand market reach Read more: CyDex Pharmaceuticals licenses compound that could expand market reach - Kansas City Business Journal
bizjournals
Saturday, August 7, 2010 - 11:59am
tags:
CyDex Pharmaceuticals, Captisol, Pfizer, Bristol-Myers Squibb, Prism Pharmaceuticals
Show Me the Money, AstraZeneca
Motley Fool
Saturday, August 7, 2010 - 11:55am
tags:
AstraZeneca
FDA Dings Novartis for Facebook Widget
WSJ
Saturday, August 7, 2010 - 11:54am
tags:
Novartis, FDA
Onyx Reports Wider Loss
Yahoo/Zacks
Saturday, August 7, 2010 - 11:53am
tags:
ONYX Pharmaceuticals, investors, earnings
Flu vaccine developer Novavax takes bigger 2Q loss
Yahoo/AP
Saturday, August 7, 2010 - 11:51am
tags:
Novavax, earnings, investors
Opexa Therapeutics Reports Second Quarter 2010 Financial Results
Yahoo/BusinessWire
Saturday, August 7, 2010 - 11:51am
tags:
Opexa, earnings, investors
Acne products boost Medicis Pharma's 2Q earnings
Yahoo/AP
Saturday, August 7, 2010 - 11:48am
tags:
Medicis, Solodyn, Triaz, Ziana, acne, dermatology, earnings, investors
Hemispherx Biopharma, Inc. 2nd Quarter 2010 Financial Results
Yahoo/GlobeNewsWire
Saturday, August 7, 2010 - 11:45am
tags:
Hemispherx, earnings, investors
Amylin Pharmaceuticals: Warming Up or Cooling Off?
Motley Fool
Saturday, August 7, 2010 - 11:44am
tags:
Amylin, investors
Osiris swings to 2Q profit
bizjournals.com
Saturday, August 7, 2010 - 11:42am
tags:
Osiris Therapeutics, earnings
GenVec says new Novartis deal could yield $13M
Yahoo/AP
Friday, August 6, 2010 - 11:48am
tags:
Novartis, GenVec
What Investors Think About Abraxis BioScience
Motley Fool
Friday, August 6, 2010 - 11:47am
tags:
companies
Osiris Therapeutics turns 2Q profit, expenses fall
Yahoo/AP
Friday, August 6, 2010 - 11:46am
tags:
Osiris Therapeutics, earnings
Ardea takes larger 2Q loss on development costs
Yahoo/AP
Friday, August 6, 2010 - 11:26am
tags:
earnings, Ardea
Cypress rebuffs Ramius buyout offer
Fierce Biotech
Friday, August 6, 2010 - 11:24am
tags:
Cypress Bioscience, Ramius, M&A
Arena Pharma plans stock offering to raise $60M
Yahoo/AP
Friday, August 6, 2010 - 11:07am
tags:
Arena Pharmaceuticals, stock offering
Teva copy of Sanofi blood thinner is close -analyst
Reuters
Friday, August 6, 2010 - 11:01am
tags:
Teva Pharmaceuticals, blood thinners, Lovenox, generics, Sanofi
Big Pharma Paying Healthy Dividends
Yahoo/IndieResearch
Friday, August 6, 2010 - 10:58am
tags:
dividends, Big Pharma, Pfizer, JNJ, GSK, Eli Lilly, Roche, Merck
[video]No Shortage of Suitors for Genzyme
Yahoo/Morningstar
Friday, August 6, 2010 - 10:57am
tags:
Genzyme, M&A, GSK, JNJ, Sanofi
What Investors Think About Abbott Laboratories
Motley Fool
Friday, August 6, 2010 - 10:54am
tags:
Abbott Laboratories, investors

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.